Relmacabtagene Autoleucel in Patients With LBCL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dehui Zou
Hematology Hospital, Chinese Academy of Medical Sciences
Principal Investigator - Depei Wu
The First Affiliated Hospital of Soochow University
Principal Investigator - Heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Principal Investigator - Hongmei Jing
Peking University Third Hospital
Principal Investigator - Huilai Zhang
Tianjin Cancer Hospital
Principal Investigator - Huiqiang Huang, PhD
Sun Yat-sen University
Principal Investigator - Jianqiu Wu
Jiangsu Provincial Tumor Hospital
Principal Investigator - Liang Huang, PhD
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Principal Investigator - Ping Li
Shanghai Tongji Hospital, Tongji University School of Medicine
Principal Investigator - Qingyuan Zhang
Harbin Medical University Tumor Hospital
Principal Investigator - Ru Feng
Southern Medical University, China
Principal Investigator - Weili Zhao, PhD
Ruijin Hospital
Principal Investigator - Wenbin Qian
Second Affiliated Hospital, School of Medicine, Zhejiang University
Principal Investigator - Yajun Li
Hunan Cancer Hospital
Principal Investigator - Yao Liu
Chongqing University Cancer Hospital
Principal Investigator - Ying Lu
Ningbo University People's Hospital
Principal Investigator - Yuhua Li
Nanfang Hospital, Southern Medical University
Principal Investigator - Zhifeng Li
The First Hospital of Xiamen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ruijin Hospital Affiliated To Shanghai Jiao Tong University School of Medicine,
Shanghai, Shanghai Municipality, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Dec 2022
- Primary completion
- 31 Dec 2024
- Completion
- 31 Dec 2024
- Last update posted
- 28 Mar 2024
- Registered enrollment
- 200
- Registry id
- NCT06142175
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.